Studying overdose review teams to improve surveillance
Part of Mental health clinical trials.
This study looks at how local overdose fatality review (OFR) teams work and how they can help track and prevent overdoses better. Researchers will also use anonymous administrative data to understand overdose patterns in Indiana. The goal is to make our surveillance systems stronger and save lives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a member of a local overdose fatality review (OFR) team in Indiana.
- Or you must be a county leader (like a police chief, judge, or public health director) from an organization that is part of the OFR team.
- If your data is being used, you are an Indiana resident who has had a fatal or non-fatal overdose, identified through official records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a court-based program that helps people with substance use find resources and treatment, with the goal of preventing overdose and supporting recovery.
This study tests a remote program to help people who use opioids or stimulants reduce their risk of overdose. It involves regular check-ins and support from close contacts.
This study looks at how people recover from an overdose and get connected to care. It interviews people who have had an overdose to understand their experience and improve access to follow-up services.
This trial tests a program where people who use opioids learn to educate their friends and family about overdose prevention. It may help build a safer support network in Baltimore.
This study tests a program to help supportive housing agencies prevent overdoses among their tenants. It is designed for agencies in New York and New Jersey that have had a recent overdose and serve at least 40 tenants.
This trial tests a support program for women in Kentucky jails who have opioid or stimulant use disorder. It aims to reduce overdose risk after release by connecting them with community support.
Hear when a new Substance-Related Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.